SB0435Enacted

Amends TCA Title 56 and Title 71.

Tennessee SB0435 mandates that health insurers and TennCare health benefit plans must provide coverage for biomarker testing effective January 1, 2026, for diagnosis, treatment, management, or monitoring of diseases when supported by medical evidence. This bill affects health insurers, TennCare enrollees, and healthcare providers by ensuring access to necessary testing without requiring multiple biopsies. Key provisions include requirements for timely prior authorization responses and a clear process for requesting exceptions to coverage policies.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee SB0435 mandates that health insurers and TennCare health benefit plans must provide coverage for biomarker testing effective January 1, 2026, for diagnosis, treatment, management, or monitoring of diseases when supported by medical evidence. This bill affects health insurers, TennCare enrollees, and healthcare providers by ensuring access to necessary testing without requiring multiple biopsies. Key provisions include requirements for timely prior authorization responses and a clear process for requesting exceptions to coverage policies.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Reeves, Shane

Details
Session

114th General Assembly

Introduced

January 28, 2025

Last Action

May 14, 2026

Comp. became Pub. Ch. 929

Subjects
Insurance, Health, AccidentHealth CareTennCare

Want to track this bill? Get instant alerts and AI-powered insights.